Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • bohemianclubman bohemianclubman Mar 11, 2013 10:48 AM Flag

    Mid Year

    NTM conference in Philadelphia on May 17th
    Results from European CF clinical phase III trial
    QIDP designation for arikace expected around mid year (per Lewis at Swank conference)
    Compassionate use program for NTM expected around mid year (also from Swank conference)
    May 31st final determination of Russell reconstitution list
    This is already March 11th

 
INSM
12.75+0.42(+3.41%)Feb 9 4:00 PMEST